Jeff Carroll
| Title | Authored on | Link to edit Content | |
|---|---|---|---|
| One patient at a time: WWU's Jeff Carroll and n-Lorem | 2021-11-02 | ||
| Psychology's Jeff Carroll co-authors new paper | 2019-08-12 | ||
| CRISPR babies: When will the world be ready? | Jeff Carroll had been married for six months when he and his wife decided not to have children. Carroll, 25 years old and a former corporal in the US Army, had just found out that he had the mutation that causes Huntington’s disease, a genetic disorder that ravages the brain and… |
2019-06-20 | |
| One Couple’s Tireless Crusade to Stop a Genetic Killer | Through mutual friends, the couple had met a scientist named (WWU Professor of Psychology) Jeff Carroll, who, like Vallabh, researches his own disorder—in his case, Huntington’s disease. He had recently partnered with a company called Ionis Pharmaceuticals to develop… |
2019-01-15 | |
| MIT Profiles in Precision Medicine: Jeff Carroll | When I was younger I watched my mother’s decline, and eventual death, from Huntington’s disease. It was a terrifying experience. So naturally when my wife and I learned that I had inherited the mutation that causes the disease, we were devastated. |
2018-10-29 | |
| WWU’s Jeff Carroll Secures New Research Funding Stream from the CHDI Foundation | 2018-09-27 | ||
| How the gene behind Huntington’s disease could be neutralized | Her most important slide showed decreases in the level of mutant huntingtin in trial participants’ CSF — indicative of reduced levels of the toxic protein in their brains — that were proportional to the amounts of drug the volunteers had received. At the two highest doses, production of the… |
2018-05-30 | |
| WWU Student Wins Summer Fellowship to Research Huntington’s Disease | 2018-05-22 | ||
| Psychology’s Jeff Carroll Awarded New $100k Grant to Research Huntington’s Disease | 2018-02-05 | ||
| Huntington’s disease: Why scientists are so excited at ‘game changing’ breakthrough | Finding a cure for any disease is a complex process. The first goal has to be ensuring any potential drug does not have toxic side effects. Therefore, the main aim of the UCL study was determining whether the experimental drug – given to the majority of the 46… |
2017-12-13 |